O-191 HER1-HER2-HER3 gene amplification and akt activation inpatients with advanced non-small cell lung cancer (NSCLC) treated with gefitinib

F. Cappuzzo, M. Varella-Garcia, L. Toschi, I. Domenichini, G. Ceresoli, V. Gregorc, W. Franklin, L. Crinò, P. Bunn Jr., F. Hirsch
  • Lung Cancer, July 2005, Elsevier
  • DOI: 10.1016/s0169-5002(05)80325-3

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Federico Cappuzzo